Table 2. Number of positive serum samples from patients with VL and with other diseases, and from healthy individuals tested with the newly developed ICT and the Kalazar Detect Rapid Test.
Serum samples | No | No of positive samples | |
---|---|---|---|
Newly developed ICT | Kalazar Detect | ||
AVL | 64 | 63 | 64 |
DST-ZVL | 71 | 66 | 62 |
MST-ZVL | 78 | 75 | 76 |
Leprosy | 31 | 1 | 3 |
Malaria | 43 | 1 | 1 |
Cystic echinococcosis | 30 | 0 | 0 |
Schistosomiasis | 25 | 0 | 0 |
Toxoplasmosis | 27 | 1 | 1 |
Healthy donors | 78 | 0 | 0 |